The Growing Case for Use of SGLT2i in Heart Failure Additional Benefits of Empagliflozin in a HFpEF Rodent Model ∗

Overview of attention for article published in JACC: Basic to Translational Science, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Drug therapies for cardiology, osteoporosis, and peanut allergies hold great potential.

Home : Headlines 2019 By Liz Hollis Staff Writer CLEVELAND The list is out, and a dual-acting osteoporosis drug and a device…